8-K - Cognition Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Other Event

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On March 2, 2026, Cognition Therapeutics, Inc. (the “Company”) issued a press release announcing its plans to advance development of zervimesine f

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits The following exhibits are being furnished herewith: Exhibit No. Document 99.1 Press Release, dated March 2, 202

Exhibits Only

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1